#USA #Minneapolis #VentureMed Group #FLEX Vessel Prep #Flex Vascular

Flex Vascular: A New Era for VentureMed Group, Inc.

On March 5, 2026, a significant transformation was announced in the medical device sector as VentureMed Group, Inc. officially began operating under the name Flex Vascular. This rebranding reflects the company’s dedicated focus on vascular innovation and aligns seamlessly with its flagship product, the FLEX Vessel Prep™ system.

Emphasizing Innovation and Clarity

Denis Harrington, the CEO, stated, "Flex Vascular represents more clearly who we are and what we do." As the FLEX Vessel Prep technology gains traction in the medical community, it became essential for the public name to correspond with the company’s vascular-centric mission and advanced technological contributions to clinicians and patients alike. This new identity serves as a beacon of the company's commitment to enhancing vascular patient care and optimizing existing medical procedures.

Despite the name change, it's important to note that the legal entity—VentureMed Group, Inc.—remains unchanged. The transition signifies a brand update rather than a restructuring of ownership, leadership, product offerings, or regulatory status, ensuring continued reliability and trust in existing relationships with clients and stakeholders.

The Cornerstone Technology: FLEX Vessel Prep™

At the heart of Flex Vascular's operations is the FLEX Vessel Prep™ system, a device that has received 510(k) clearance from the FDA and CE marking, acknowledging its safety and efficacy. This proprietary tool utilizes a unique Kinetic Endovascular Micro-incision Creation (KEMIC) technology, differentiating itself from traditional balloon-based vessel preparation techniques that often rely on static pressure.

KEMIC provides a dynamic process that creates precise, long micro-incisions while actively engaging the vessel wall through controlled movement. This method of treatment not only facilitates better luminal gain, which is critical in vascular surgeries, but also enhances drug absorption when used in combination therapies, reducing trauma to the vessel and minimizing the risk of restenosis—a common complication in vascular procedures.

It’s Business as Usual

Customers, partners, and stakeholders can expect to see the Flex Vascular name in various communications, marketing materials, and digital platforms moving forward. However, this change does not affect existing contracts, pricing structures, product availability, or customer support protocols, ensuring a seamless experience for all involved.

Flex Vascular aims to foster innovation in the field of vascular access and care, reinforcing its position as a leader in the medical device space. The company’s dedication to producing forward-thinking solutions aligns with the evolving landscape of healthcare, where efficiency and patient outcomes are paramount.

For more information about Flex Vascular and its groundbreaking technology, visit www.FlexVascular.com.

As Flex Vascular sets forth on this new chapter, the potential for advancements in vascular treatment and patient care is greater than ever, promising a brighter future for innovation in the health tech landscape.

About Flex Vascular

Flex Vascular, a private company based in Minnesota, is renowned for its pioneering work in medical devices, particularly in the development of endovascular solutions. The FLEX Vessel Prep™ system stands as a testament to the company's commitment to improving vascular intervention techniques while maintaining a focus on patient safety and clinical efficacy.